The Efficacy of Treatments to Improve Self-esteem
The goal of this study is to examine the effectivity of two self-esteem interventions (COMET (Korrelboom) and CBT (De Neef)) in a general psychiatric population. The main questions it aims to answer are: * is there a difference between the two interventions in effectiveness on increasing self-esteem? * is there a diffe
| Condition(s) | Self Esteem |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this study is to examine the effectivity of two self-esteem interventions (COMET (Korrelboom) and CBT (De Neef)) in a general psychiatric population. The main questions it aims to answer are: * is there a difference between the two interventions in effectiveness on increasing self-esteem? * is there a difference between the two interventions in effect on levels of anxiety, depression and general mental health? * are found effects on levels of anxiety, depression and general mental health associated with changes in self-esteem? * is the ability to use imagination a moderator for outcomes in both conditions? Participants are randomised over both conditions. At baseline (T0), end of treatment (T1) and follow-up at 6 months (T2) several outcome measures are conducted, such as RSES, |
| Who can participate | Inclusion Criteria: \- A self-perceived low self-esteem established by both patient and caregiver by means of (consent to) referral for self-esteem treatment. Exclusion Criteria: * severe suicidality for which hospitalization or other forms of crisis care is necessary, * acute psychosis, * current manic episode, * current alcohol or drug abuse, * insufficient knowledge of the Dutch language, * illiteracy * being unable to identify at least one positive aspect of oneself, which does not need to be felt as convincing for the participant. The latter is an excluding criterium formulated by the COMET protocol. |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Lead sponsor | GGZ Noord-Holland-Noord |
| Locations | Heerhugowaard, North Holland, Netherlands |
| Start date | 2023-11-01 |
| NCT ID | NCT06101810 |
| Official listing | https://clinicaltrials.gov/study/NCT06101810 |